BioSpace News Archive

Arcutis, Inc. provided details on the ARQ-151 clinical development program for plaque psoriasis.

The Institute for Clinical and Economic Review (ICER) has reached an agreement with IPD Analytics LLC (IPD) whereby ICER will leverage IPD’s data, expertise and assessments to advance their horizon scanning efforts across the pharmaceutical and biologic markets.

Avanos Medical, Inc. announced that it commenced a cash tender offer to purchase up to $129,840,000 in aggregate purchase price of its outstanding 6.250 percent Senior Unsecured Notes due October 15, 2022.

ICON plc announced the release of its web based patient engagement platform, to provide patients with study specific information and connectivity with the nearest investigative site.

“This first quarter of 2019, we were busy ensuring that the recruitment efforts for our pivotal phase 3 study NefIgArd remain on track, focusing on site initiation visits and supporting our CRO in their work to ensure that all sites are brought online on a timely manner.

HOOKIPA Pharma Inc. (NASDAQ: HOOK), a company developing a new class of immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform, today announced that it has achieved a further research milestone in its collaboration and license agreement with Gilead Sciences, Inc.

Aurinia Pharmaceuticals Inc. announced that it will release its first quarter 2019 financial results on Tuesday, May 14, 2019, after the market closes.

BioTime, Inc. reported financial and operating results for the first quarter ended March 31, 2019.

Smart Microscopy from ZEISS is a new concept for the routine digital documentation of microscopic samples. The microscopes ZEISS Axiolab 5 and ZEISS Axioscope 5, as well as the microscope cameras ZEISS Axiocam 202 mono and ZEISS Axiocam 208 color, can be combined to form a Smart Microscopy system that takes away a large share of the workload from the users.

Boston Scientific (NYSE: BSX) has announced that it has entered into a definitive agreement to acquire Vertiflex, Inc., a privately-held company which has developed and commercialized the Superion® Indirect Decompression System,